<i>SETD2</i> Deficiency Confers Sensitivity to Dual Inhibition of DNA Methylation and PARP in Kidney Cancer
Xinyi Zhou(University of Southern California), Gangning Liang(USC Norris Comprehensive Cancer Center)
Cited by 19
Related Papers
Distinct localization of histone H3 acetylation and H3-K4 methylation to the transcription start sites in the human genome
|Proceedings of the National Academy of Sciences|2004|490
Role of Nucleosomal Occupancy in the Epigenetic Silencing of the MLH1 CpG Island
|Cancer Cell|2007|203
Clinical evaluation of Bladder CARE, a new epigenetic test for bladder cancer detection in urine samples
|Clinical Epigenetics|2021|45
Dnmt3a2 expression during embryonic development is required for phenotypic stability
|Research Square|2025|0